The global Biologics and Biosimilars market size is estimated to be $xx million in 2023, and it will reach $xx million by 2032, growing at a CAGR of xx% during the forecast period from 2024 to 2032.
This report studies the Biologics and Biosimilars market, covering market size for segment by type (Monoclonal Antibodies, Interferon, etc.), by application (Tumor, Diabetes, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Biologics and Biosimilars from 2018-2023, and provides extensive market forecasts from 2024-2032 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Biologics and Biosimilars market.
Leading Players of Biologics and Biosimilars including:
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
Market split by Type:
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
Market split by Application:
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Market split by Sales Channel:
Direct Channel
Distribution Channel
Market split by Region/Country:
North America (United States and Canada)
Europe (Germany, UK, France, Italy, Spain, and Russia, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia, etc.)
South America (Brazil, Mexico, and Argentina, etc.)
Middle East & Africa (Turkey, UAE, Saudi Arabia, and South Africa, etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
TABLE OF CONTENTS
Table of Contents
Chapter 1 Biologics and Biosimilars Market Overview
1.1 Biologics and Biosimilars Definition
1.2 Global Biologics and Biosimilars Market Size Status and Outlook (2018-2032)
1.3 Global Biologics and Biosimilars Market Size Comparison by Region (2018-2032)
1.4 Global Biologics and Biosimilars Market Size Comparison by Type (2018-2032)
1.5 Global Biologics and Biosimilars Market Size Comparison by Application (2018-2032)
1.6 Global Biologics and Biosimilars Market Size Comparison by Sales Channel (2018-2032)
1.7 Biologics and Biosimilars Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Merger/Acquisition/Expansion)
1.7.4 Key Trends in Biologics and Biosimilars Market
Chapter 2 Biologics and Biosimilars Market Competition by Player
2.1 Global Biologics and Biosimilars Sales and Market Share by Player (2021-2023)
2.2 Global Biologics and Biosimilars Revenue and Market Share by Player (2021-2023)
2.3 Global Biologics and Biosimilars Average Price by Player (2021-2023)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Biologics and Biosimilars Market Segment by Type
3.1 Global Biologics and Biosimilars Market by Type
3.1.1 Monoclonal Antibodies
3.1.2 Interferon
3.1.3 Erythropoietin
3.1.4 Insulin
3.1.5 Vaccines
3.2 Global Biologics and Biosimilars Sales and Market Share by Type (2018-2023)
3.3 Global Biologics and Biosimilars Revenue and Market Share by Type (2018-2023)
3.4 Global Biologics and Biosimilars Average Price by Type (2018-2023)
3.5 Conclusion of Segment by Type
Chapter 4 Biologics and Biosimilars Market Segment by Application
4.1 Global Biologics and Biosimilars Market by Application
4.1.1 Tumor
4.1.2 Diabetes
4.1.3 Cardiovascular
4.1.4 Hemophilia
4.1.5 Other
4.2 Global Biologics and Biosimilars Revenue and Market Share by Application (2018-2023)
4.3 Conclusion of Segment by Application
Chapter 5 Biologics and Biosimilars Market Segment by Sales Channel
5.1 Global Biologics and Biosimilars Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Biologics and Biosimilars Revenue and Market Share by Sales Channel (2018-2023)
5.3 Conclusion of Segment by Sales Channel
Chapter 6 Biologics and Biosimilars Market Segment by Region & Country
6.1 Global Biologics and Biosimilars Market Size and CAGR by Region (2018-2032)
6.2 Global Biologics and Biosimilars Sales and Market Share by Region (2018-2023)
6.3 Global Biologics and Biosimilars Revenue and Market Share by Region (2018-2023)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Biologics and Biosimilars Market Share by Type
6.4.3 North America Biologics and Biosimilars Market Share by Application
6.4.4 United States
6.4.5 Canada
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Biologics and Biosimilars Market Share by Type
6.5.3 Europe Biologics and Biosimilars Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Spain
6.5.9 Russia
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Biologics and Biosimilars Market Share by Type
6.6.3 Asia-Pacific Biologics and Biosimilars Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Biologics and Biosimilars Market Share by Type
6.7.3 South America Biologics and Biosimilars Market Share by Application
6.7.4 Brazil
6.7.5 Mexico
6.7.6 Argentina
6.7.7 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Biologics and Biosimilars Market Share by Type
6.8.3 Middle East & Africa Biologics and Biosimilars Market Share by Application
6.8.4 Turkey
6.8.5 UAE
6.8.6 Saudi Arabia
6.8.7 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Biologics and Biosimilars Players
7.1 Roche
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Amgen
7.3 AbbVie
7.4 Sanofi-Aventis
7.5 Johnson & Johnson
7.6 Pfizer
7.7 Novo Nordisk
7.8 Eli Lilly
7.9 Novartis
7.10 Merck
7.11 3sbio
7.12 Changchun High Tech
7.13 CP Guojian
7.14 Biotech
7.15 Gelgen
7.16 Innovent
7.17 Dong Bao
7.18 Ganlee
Chapter 8 Upstream and Downstream Analysis of Biologics and Biosimilars
8.1 Industrial Chain of Biologics and Biosimilars
8.2 Upstream of Biologics and Biosimilars
8.3 Downstream of Biologics and Biosimilars
Chapter 9 Development Trend of Biologics and Biosimilars (2024-2032)
9.1 Global Biologics and Biosimilars Market Size (Sales and Revenue) Forecast (2024-2032)
9.2 Global Biologics and Biosimilars Market Size and CAGR Forecast by Region (2024-2032)
9.3 Global Biologics and Biosimilars Market Size and CAGR Forecast by Type (2024-2032)
9.4 Global Biologics and Biosimilars Market Size and CAGR Forecast by Application (2024-2032)
9.5 Global Biologics and Biosimilars Market Size and CAGR Forecast by Sales Channel (2024-2032)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure Biologics and Biosimilars Example
Figure Global Biologics and Biosimilars Revenue (Million $) Status and Outlook (2018-2032)
Figure Global Biologics and Biosimilars Revenue (Million $) Comparison by Region (2018-2032)
Figure Global Biologics and Biosimilars Revenue (Million $) Comparison by Type (2018-2032)
Figure Global Biologics and Biosimilars Revenue (Million $) Comparison by Application (2018-2032)
Figure Global Biologics and Biosimilars Revenue (Million $) Comparison by Sales Channel (2018-2032)
Table Global Biologics and Biosimilars Sales by Player (2021-2023)
Table Global Biologics and Biosimilars Sales Market Share by Player (2021-2023)
Figure Global Biologics and Biosimilars Sales Market Share by Player in 2023
Table Global Biologics and Biosimilars Revenue (Million $) by Player (2021-2023)
Table Global Biologics and Biosimilars Revenue Market Share by Player (2021-2023)
Figure Global Biologics and Biosimilars Revenue Market Share by Player in 2023
Table Global Biologics and Biosimilars Average Price by Player (2021-2023)
Figure Global Biologics and Biosimilars Average Price by Player in 2023
Figure Global Biologics and Biosimilars Players Competition Situation ? Top 5 Players? Revenue Market Share in 2021
Figure Global Biologics and Biosimilars Players Competition Trends ? Top 5 Players? Revenue Market Share in 2023
Figure Example of Monoclonal Antibodies
Figure Global Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Interferon
Figure Global Interferon Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Erythropoietin
Figure Global Erythropoietin Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Insulin
Figure Global Insulin Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Vaccines
Figure Global Vaccines Revenue (Million $) and Growth Rate (2018-2023)
Table Global Biologics and Biosimilars Sales by Type (2018-2023)
Table Global Biologics and Biosimilars Sales Market Share by Type (2018-2023)
Figure Global Biologics and Biosimilars Sales Market Share by Type in 2023
Table Global Biologics and Biosimilars Revenue (Million $) by Type (2018-2023)
Table Global Biologics and Biosimilars Revenue Market Share by Type (2018-2023)
Figure Global Biologics and Biosimilars Revenue Market Share by Type in 2023
Table Global Biologics and Biosimilars Average Price by Type (2018-2023)
Figure Global Biologics and Biosimilars Average Price by Type in 2023
Table Leading Players of Biologics and Biosimilars by Type in 2023
Figure Example of Tumor
Figure Global Biologics and Biosimilars for Tumor Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Diabetes
Figure Global Biologics and Biosimilars for Diabetes Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Cardiovascular
Figure Global Biologics and Biosimilars for Cardiovascular Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Hemophilia
Figure Global Biologics and Biosimilars for Hemophilia Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Other
Figure Global Biologics and Biosimilars for Other Revenue (Million $) and Growth Rate (2018-2023)
Table Global Biologics and Biosimilars Sales by Application (2018-2023)
Table Global Biologics and Biosimilars Sales Market Share by Application (2018-2023)
Figure Global Biologics and Biosimilars Sales Market Share by Application in 2023
Table Leading Consumers of Biologics and Biosimilars by Application in 2023
Figure Example of Direct Channel
Figure Global Biologics and Biosimilars for Direct Channel Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Distribution Channel
Figure Global Biologics and Biosimilars for Distribution Channel Revenue (Million $) and Growth Rate (2018-2023)
Table Global Biologics and Biosimilars Revenue by Sales Channel (2018-2023)
Table Global Biologics and Biosimilars Revenue Market Share by Sales Channel (2018-2023)
Figure Global Biologics and Biosimilars Revenue Market Share by Sales Channel in 2023
Table Leading Distributors/Dealers of Biologics and Biosimilars by Sales Channel in 2023
Table Global Biologics and Biosimilars Market Size and CAGR by Region (2018-2032)
Table Global Biologics and Biosimilars Sales by Region (2018-2023)
Table Global Biologics and Biosimilars Sales Market Share by Region (2018-2023)
Figure Global Biologics and Biosimilars Sales Market Share by Region in 2023
Table Global Biologics and Biosimilars Revenue (Million $) by Region (2018-2023)
Table Global Biologics and Biosimilars Revenue Market Share by Region (2018-2023)
Figure Global Biologics and Biosimilars Revenue Market Share by Region in 2023
Table North America Biologics and Biosimilars Sales by Country (2018-2023)
Figure North America Biologics and Biosimilars Sales Market Share by Country (2018-2023)
Table North America Biologics and Biosimilars Revenue by Country (2018-2023)
Figure North America Biologics and Biosimilars Revenue Market Share by Country (2018-2023)
Figure North America Biologics and Biosimilars Market Share by Type in 2023
Figure North America Biologics and Biosimilars Market Share by Application in 2023
Figure United States Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure United States Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Figure Canada Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure Canada Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Table Europe Biologics and Biosimilars Sales by Country (2018-2023)
Figure Europe Biologics and Biosimilars Sales Market Share by Country (2018-2023)
Table Europe Biologics and Biosimilars Revenue by Country (2018-2023)
Figure Europe Biologics and Biosimilars Revenue Market Share by Country (2018-2023)
Figure Europe Biologics and Biosimilars Market Share by Type in 2023
Figure Europe Biologics and Biosimilars Market Share by Application in 2023
Figure Germany Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure Germany Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Figure UK Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure UK Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Figure France Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure France Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Figure Italy Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure Italy Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Figure Spain Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure Spain Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Figure Russia Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure Russia Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Table Asia-Pacific Biologics and Biosimilars Sales by Country (2018-2023)
Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Country (2018-2023)
Table Asia-Pacific Biologics and Biosimilars Revenue by Country (2018-2023)
Figure Asia-Pacific Biologics and Biosimilars Revenue Market Share by Country (2018-2023)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Type in 2023
Figure Asia-Pacific Biologics and Biosimilars Market Share by Application in 2023
Figure China Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure China Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Figure Japan Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure Japan Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Figure Korea Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure Korea Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Figure India Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure India Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Figure Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure Southeast Asia Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Figure Australia Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure Australia Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Table South America Biologics and Biosimilars Sales by Country (2018-2023)
Figure South America Biologics and Biosimilars Sales Market Share by Country (2018-2023)
Table South America Biologics and Biosimilars Revenue by Country (2018-2023)
Figure South America Biologics and Biosimilars Revenue Market Share by Country (2018-2023)
Figure South America Biologics and Biosimilars Market Share by Type in 2023
Figure South America Biologics and Biosimilars Market Share by Application in 2023
Figure Brazil Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure Brazil Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Figure Mexico Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure Mexico Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Figure Argentina Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure Argentina Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Figure Colombia Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure Colombia Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Table Middle East & Africa Biologics and Biosimilars Sales by Country (2018-2023)
Figure Middle East & Africa Biologics and Biosimilars Sales Market Share by Country (2018-2023)
Table Middle East & Africa Biologics and Biosimilars Revenue by Country (2018-2023)
Figure Middle East & Africa Biologics and Biosimilars Revenue Market Share by Country (2018-2023)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Type in 2023
Figure Middle East & Africa Biologics and Biosimilars Market Share by Application in 2023
Figure Turkey Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure Turkey Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Figure UAE Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure UAE Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Figure Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure Saudi Arabia Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Figure South Africa Biologics and Biosimilars Sales and Growth Rate (2018-2023)
Figure South Africa Biologics and Biosimilars Revenue (Million $) and Growth Rate (2018-2023)
Table Company Snapshot of Roche
Table Biologics and Biosimilars Introduction of Roche
Table Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share of Roche (2021-2023)
Table Industrial Chain of Biologics and Biosimilars
Table Leading Consumers of Biologics and Biosimilars
Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast (2024-2032)
Figure Global Biologics and Biosimilars Revenue and Growth Rate Forecast (2024-2032)
Table Global Biologics and Biosimilars Market Size and CAGR Forecast by Region (2024-2032)
Table Global Biologics and Biosimilars Market Size and CAGR Forecast by Type (2024-2032)
Table Global Biologics and Biosimilars Market Size and CAGR Forecast by Application (2024-2032)
Table Global Biologics and Biosimilars Market Size and CAGR Forecast by Sales Channel (2024-2032)
